dividing bar

Issue Brief 14 - CMS Cutbacks on Reimbursement Rates May Effect Colonoscopy Screening Availability

Tuesday, August 9, 2016

 

Issue Brief 14 thumbnailCMS Cutbacks on Reimbursement Rates May Effect Colonoscopy Screening Availability (HTML | PDF)

In the United States, colorectal cancer is the second leading cause of cancer related deaths and yet it is one of the cancers that through screening and healthy choices is preventable and treatable. The Gold Standard for colorectal cancer screening is a colonoscopy utilizing propofol. Since the introduction of propofol as an anesthesia agent, studies have shown that actual procedure times have been reduced but the American Gastroenterological Association argues that changes in technology and screening guidelines have increased the time and intensity of the work. The U.S. Center for Medicare and Medicaid Services (CMS) reduced the reimbursement rate for colonoscopy up to 17 percent on the recommendation of the Relative Value Unit Update Committee.

Startup Growth Lite is a free theme, contributed to the Drupal Community by More than Themes.